Evidence map›Paper›PMID 26445441›Full record

ArticleBiophysical journal2015

Differential Redox Regulation of Ca²⁺ Signaling and Viability in Normal and Malignant Prostate Cells.

Christian Holzmann, Tatiana Kilch, Sven Kappel, Kathrin Dörr, Volker Jung, Michael Stöckle, Ivan Bogeski, Christine Peinelt

Abstract read
In one paragraph

Article in Biophysical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Reactive Oxygen Species and Endothelial CaInternational journal of molecular sciences · 2021
    Review
  8. Article
  9. Review
  10. Review
  11. The Number and Position of Orai3 Units within Heteromeric Store-Operated CaInternational journal of molecular sciences · 2020
    Article
  12. Article
  13. Review
  14. Article
  15. The role of the mitochondrial calcium uniporter (MCU) complex in cancer.Pflugers Archiv : European journal of physiology · 2018
    Review
  16. Review
  17. Store-Operated CaCurrent molecular biology reports · 2017
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christian HolzmannBiophysics, Center for Integrated Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.
Tatiana KilchBiophysics, Center for Integrated Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany; Center of Human and Molecular Biology, Saarland University, Homburg, Germany.
Sven KappelBiophysics, Center for Integrated Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.
Kathrin DörrBiophysics, Center for Integrated Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.
Volker JungClinics of Urology and Pediatric Urology, Saarland University, Homburg, Germany.
Michael StöckleClinics of Urology and Pediatric Urology, Saarland University, Homburg, Germany.
Ivan BogeskiBiophysics, Center for Integrated Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany.
Christine PeineltBiophysics, Center for Integrated Physiology and Molecular Medicine, School of Medicine, Saarland University, Homburg, Germany; Center of Human and Molecular Biology, Saarland University, Homburg, Germany. Electronic address: bpcpei@uks.eu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In prostate cancer, reactive oxygen species (ROS) are elevated and Ca(2+) signaling is impaired. Thus, several novel therapeutic strategies have been developed to target altered ROS and Ca(2+) signaling pathways in prostate cancer. Here, we investigate alterations of intracellular Ca(2+) and inhibition of cell viability caused by ROS in primary human prostate epithelial cells (hPECs) from healthy tissue and prostate cancer cell lines (LNCaP, DU145, and PC3). In hPECs, LNCaP and DU145 H2O2 induces an initial Ca(2+) increase, which in prostate cancer cells is blocked at high concentrations of H2O2. Upon depletion of intracellular Ca(2+) stores, store-operated Ca(2+) entry (SOCE) is activated. SOCE channels can be formed by hexameric Orai1 channels; however, Orai1 can form heteromultimers with its homolog, Orai3. Since the redox sensor of Orai1 (Cys-195) is absent in Orai3, the Orai1/Orai3 ratio in T cells determines the redox sensitivity of SOCE and cell viability. In prostate cancer cells, SOCE is blocked at lower concentrations of H2O2 compared with hPECs. An analysis of data from hPECs, LNCaP, DU145, and PC3, as well as previously published data from naive and effector TH cells, demonstrates a strong correlation between the Orai1/Orai3 ratio and the SOCE redox sensitivity and cell viability. Therefore, our data support the concept that store-operated Ca(2+) channels in hPECs and prostate cancer cells are heteromeric Orai1/Orai3 channels with an increased Orai1/Orai3 ratio in cells derived from prostate cancer tumors. In addition, ROS-induced alterations in Ca(2+) signaling in prostate cancer cells may contribute to the higher sensitivity of these cells to ROS.

Indexed as

CalciumCalcium ChannelsCalcium SignalingCell Line, TumorCell SurvivalEpithelial CellsGene Knockdown TechniquesHumansHydrogen PeroxideIntracellular SpaceMaleMembrane ProteinsNeoplasm ProteinsORAI1 ProteinOxidation-ReductionPatch-Clamp TechniquesCalciumCalcium ChannelsHydrogen PeroxideMembrane ProteinsNeoplasm ProteinsORAI1 ProteinORAI1 protein, humanOrai3 protein, humanReactive Oxygen SpeciesSTIM1 protein, humanStromal Interaction Molecule 1

Identifiers

PMID26445441
PMCPMC4601090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.